AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Protect Pharmaceutical Corporation

$0.25 +$0.16 (+171.74%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.2
Day Range
$0.15$0.25
Year Range
$0.02$0.62
Market Cap
14.36M
AVG Volume
23.69K
Trailing/Forward PE
-668.04/-
PEG ratio
6.68
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
020M40M60M80M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q226 Q126 Q2
PRTT Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q20
26 Q10
25 Q226.34M
25 Q125.66M
24 Q429.73M
24 Q330.66M
24 Q245.45M
24 Q126.42M
23 Q437.5M
23 Q366.88M
Net Income (USD)
-10M010M20M30M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q226 Q126 Q2
PRTT Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-20K
26 Q1-1.5K
25 Q26.63M
25 Q16.56M
24 Q410.06M
24 Q326.09M
24 Q213.48M
24 Q16.7M
23 Q414.16M
23 Q323.19M
Operating Income (USD)
-10M010M20M30M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q226 Q126 Q2
PRTT Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-20K
26 Q1-1.5K
25 Q28.84M
25 Q18.75M
24 Q410.26M
24 Q321.87M
24 Q213.48M
24 Q17.81M
23 Q413.52M
23 Q324.3M
EBITDA (USD)
-10M010M20M30M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q226 Q126 Q2
PRTT EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-20K
26 Q1-1.5K
25 Q28.84M
25 Q18.75M
24 Q410.26M
24 Q321.87M
24 Q213.48M
24 Q112.03M
23 Q413.56M
23 Q324.3M
Cash Flows (USD)
-40M-20M020M40M23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
PRTT Cash Flows (USD) by quarter
PeriodCash Flows (USD)
25 Q2-4.57M
25 Q11.92M
24 Q45.8M
24 Q3-464K
24 Q22.58M
24 Q11.92M
23 Q4-23.23M
23 Q330.15M
23 Q2-3.38M
23 Q1499K
EPS (USD)
00.20.40.623 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q226 Q126 Q2
PRTT EPS (USD) by quarter
PeriodEPS (USD)
26 Q20
26 Q10
25 Q20.12
25 Q10.11
24 Q40.18
24 Q30.45
24 Q20.23
24 Q10.12
23 Q40.25
23 Q30.4
Expenses (USD)
-5M05M10M15MR&DSG&ACapex23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q226 Q126 Q2
PRTT Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q20
23 Q10
26 Q220K
26 Q11.5K
25 Q28.3M
25 Q16.15M
24 Q46.28M
24 Q3-4.19M
24 Q27.32M
24 Q18.38M
23 Q46.67M
23 Q312.14M
Cash & Debt (USD)
025M50M75M100MCashLong Term DebtShort Term Debt23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
PRTT Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
25 Q275.76M
25 Q168.88M
24 Q473.94M
24 Q363.55M
24 Q263.02M
24 Q160.74M
23 Q465.11M
23 Q389.38M
23 Q253.81M
23 Q155.28M
Debt ratios
-6-4-2023 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
PRTT Debt ratios by quarter
PeriodDebt ratios
25 Q2-1.44
25 Q1-1.19
24 Q4-1.22
24 Q3-0.98
24 Q2-0.93
24 Q1-1.12
23 Q4-1.28
23 Q3-2.5
23 Q2-5.05
23 Q1-5.51
Margins
0%20%40%60%80%23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
PRTT Margins by quarter
PeriodMargins
25 Q255.7%
25 Q156.08%
24 Q453.89%
24 Q371.45%
24 Q245.76%
24 Q152.35%
23 Q453.85%
23 Q354.49%
23 Q269.6%
23 Q151.62%
Return on Capital
0%2.5%5%7.5%10%23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
PRTT Return on Capital by quarter
PeriodReturn on Capital
25 Q21.92%
25 Q11.93%
24 Q43.02%
24 Q38.06%
24 Q24.54%
24 Q12.37%
23 Q45.13%
23 Q38.86%
23 Q20.27%
23 Q13.33%
Shares Outstanding
020M40M60M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q226 Q126 Q2
PRTT Shares Outstanding by quarter
PeriodShares Outstanding
26 Q257.45M
26 Q157.45M
25 Q257.45M
25 Q157.45M
24 Q457.45M
24 Q357.45M
24 Q257.45M
24 Q157.45M
23 Q457.45M
23 Q357.45M
Book Value Per Share (USD)
0246823 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
PRTT Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
25 Q26.02
25 Q15.91
24 Q45.79
24 Q35.63
24 Q25.16
24 Q14.93
23 Q44.81
23 Q34.56
23 Q24.15
23 Q14.14
Total Assets (USD)
0200M400M600M23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
PRTT Total Assets (USD) by quarter
PeriodTotal Assets (USD)
25 Q2423.3M
25 Q1419.04M
24 Q4417.63M
24 Q3399.55M
24 Q2378.27M
24 Q1370.89M
23 Q4366.36M
23 Q3375.96M
23 Q2349.81M
23 Q1350.75M
PE Ratio
00.511.52med 0.53Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PRTT PE Ratio by quarter
PeriodPE Ratio
Sep 260.62
Sep 260.49
Sep 260.44
Aug 260.44
Aug 260.62
Aug 260.74
Aug 260.86
Jul 261.11
Jul 261.11
Jul 260.59
Jul 260.69
Jul 260.19
Jun 260.07
Jun 260.08
Jun 260.13
Jun 260.07
May 260.07
May 260.1
May 260.1
May 260.1
May 260.07
Apr 260.06
Apr 260.06
Apr 260.06
Apr 260.06
Mar 260.06
Mar 260.07
Mar 260.12
Mar 260.12
Feb 260.09
Feb 260.09
Feb 260.17
Feb 260.07
Jan 260.09
Jan 260.09
Jan 260.06
Jan 260.07
Jan 260.11
Dec 250.12
Dec 250.1
Dec 250.13
Dec 250.14
Nov 250.22
Nov 250.22
Nov 250.23
Nov 250.22
Oct 250.19
Oct 250.26
Oct 250.26
Oct 250.28
Oct 250.28
Sep 250.36
Sep 250.39
Sep 250.51
Sep 250.36
Aug 250.53
Aug 250.65
Aug 250.7
Aug 250.41
Aug 250.56
Jul 250.87
Jul 250.77
Jul 250.89
Jul 251
Jun 251.16
Jun 251.16
Jun 251.13
Jun 251.22
May 251.25
May 251.25
May 251.33
May 251.16
May 251.19
Apr 251.35
Apr 251.16
Apr 251.16
Apr 251.33
Mar 251.44
Mar 251.41
Mar 251.25
Mar 251.51
Feb 251.02
Feb 250.98
Feb 251.11
Feb 250.83
Jan 250.58
Jan 250.57
Jan 250.5
Jan 250.52
Jan 250.55
Dec 240.54
Dec 240.6
Dec 240.71
Dec 240.77
Nov 240.89
Nov 240.91
Nov 241
Nov 240.97
Nov 241
Oct 240.81
Free Cash Flow Yield
-100%-50%0%50%100%med 22.91%Oct 24Jan 25May 25Aug 25Nov 25Mar 26Jun 26
PRTT Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Jun 2677.95%
Jun 2669.29%
Jun 2642.52%
Jun 2679.27%
May 2679.27%
May 2651.97%
May 2651.97%
May 2651.97%
May 2677.95%
Apr 2693.54%
Apr 2693.54%
Apr 2693.54%
Apr 2691.71%
Mar 2691.71%
Mar 2675.44%
Mar 2646.77%
Mar 2646.77%
Feb 2662.36%
Feb 2662.36%
Feb 2631.18%
Feb 2677.95%
Jan 2658.46%
Jan 2658.46%
Jan 2693.54%
Jan 2677.95%
Jan 2650.84%
Dec 2546.77%
Dec 2555.02%
Dec 2542.52%
Dec 2538.34%
Nov 2524.75%
Nov 2524.77%
Nov 2523.92%
Nov 2525.28%
Oct 2528.35%
Oct 2521.26%
Oct 2521.26%
Oct 2519.49%
Oct 2519.65%
Sep 2548.94%
Sep 2544.76%
Sep 2534.12%
Sep 2548.94%
Aug 2532.87%
Aug 2526.85%
Aug 2525.01%
Aug 2542.7%
Aug 2531.14%
Jul 2520.15%
Jul 2522.84%
Jul 2519.57%
Jul 2517.44%
Jun 2515.03%
Jun 2515.03%
Jun 2515.44%
Jun 2514.28%
May 2513.93%
May 2513.93%
May 2513.18%
May 2515.03%
May 2514.64%
Apr 2512.98%
Apr 2515.03%
Apr 2515.03%
Apr 2513.18%
Mar 25-22.12%
Mar 25-22.57%
Mar 25-25.3%
Mar 25-21.01%
Feb 25-31.21%
Feb 25-32.43%
Feb 25-28.55%
Feb 25-38.37%
Jan 25-54.75%
Jan 25-55.66%
Jan 25-63.02%
Jan 25-60.76%
Jan 25-57.88%
Dec 2436.5%
Dec 2433.15%
Dec 2428.01%
Dec 2425.72%
Nov 2422.35%
Nov 2421.86%
Nov 2419.89%
Nov 2420.56%
Nov 2419.89%
Oct 2424.56%
Oct 2418.08%
Oct 2422.99%
Oct 2419.5%
Sep 247.05%
Sep 245.6%
Sep 245.29%
Sep 245.73%
Aug 244.36%
Aug 243.93%
Aug 244.96%
Aug 245.06%
Aug 245.56%
Price to Sales
00.20.40.60.8med 0.18Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PRTT Price to Sales by quarter
PeriodPrice to Sales
Sep 260.18
Sep 260.14
Sep 260.13
Aug 260.13
Aug 260.18
Aug 260.21
Aug 260.25
Jul 260.32
Jul 260.32
Jul 260.17
Jul 260.2
Jul 260.05
Jun 260.03
Jun 260.03
Jun 260.06
Jun 260.03
May 260.03
May 260.05
May 260.05
May 260.05
May 260.03
Apr 260.03
Apr 260.03
Apr 260.03
Apr 260.03
Mar 260.03
Mar 260.03
Mar 260.05
Mar 260.05
Feb 260.04
Feb 260.04
Feb 260.08
Feb 260.03
Jan 260.04
Jan 260.04
Jan 260.03
Jan 260.03
Jan 260.05
Dec 250.05
Dec 250.04
Dec 250.06
Dec 250.06
Nov 250.1
Nov 250.1
Nov 250.1
Nov 250.09
Oct 250.08
Oct 250.11
Oct 250.11
Oct 250.12
Oct 250.12
Sep 250.15
Sep 250.17
Sep 250.22
Sep 250.15
Aug 250.23
Aug 250.28
Aug 250.3
Aug 250.18
Aug 250.24
Jul 250.37
Jul 250.33
Jul 250.38
Jul 250.43
Jun 250.5
Jun 250.5
Jun 250.48
Jun 250.52
May 250.53
May 250.53
May 250.56
May 250.5
May 250.51
Apr 250.57
Apr 250.5
Apr 250.5
Apr 250.56
Mar 250.62
Mar 250.61
Mar 250.54
Mar 250.65
Feb 250.44
Feb 250.42
Feb 250.48
Feb 250.36
Jan 250.25
Jan 250.25
Jan 250.22
Jan 250.23
Jan 250.24
Dec 240.18
Dec 240.2
Dec 240.23
Dec 240.25
Nov 240.29
Nov 240.3
Nov 240.33
Nov 240.32
Nov 240.33
Oct 240.26
EV/EBITDA
-2-1012med -0.45Oct 24Jan 25May 25Aug 25Nov 25Mar 26Jun 26
PRTT EV/EBITDA by quarter
PeriodEV/EBITDA
Jun 26-1.37
Jun 26-1.36
Jun 26-1.31
Jun 26-1.37
May 26-1.37
May 26-1.33
May 26-1.33
May 26-1.33
May 26-1.37
Apr 26-1.38
Apr 26-1.38
Apr 26-1.38
Apr 26-1.38
Mar 26-1.38
Mar 26-1.36
Mar 26-1.32
Mar 26-1.32
Feb 26-1.35
Feb 26-1.35
Feb 26-1.26
Feb 26-1.37
Jan 26-1.34
Jan 26-1.34
Jan 26-1.38
Jan 26-1.37
Jan 26-1.33
Dec 25-1.32
Dec 25-1.34
Dec 25-1.31
Dec 25-1.29
Nov 25-1.22
Nov 25-1.22
Nov 25-1.21
Nov 25-1.22
Oct 25-1.24
Oct 25-1.18
Oct 25-1.18
Oct 25-1.16
Oct 25-1.16
Sep 25-0.82
Sep 25-0.79
Sep 25-0.66
Sep 25-0.82
Aug 25-0.64
Aug 25-0.52
Aug 25-0.47
Aug 25-0.77
Aug 25-0.61
Jul 25-0.29
Jul 25-0.4
Jul 25-0.27
Jul 25-0.15
Jun 25-0.08
Jun 25-0.08
Jun 25-0.11
Jun 25-0.02
May 250.01
May 250.01
May 250.08
May 25-0.08
May 25-0.05
Apr 250.1
Apr 25-0.08
Apr 25-0.08
Apr 250.08
Mar 250.44
Mar 250.42
Mar 250.26
Mar 250.52
Feb 250.03
Feb 25-0.01
Feb 250.12
Feb 25-0.16
Jan 25-0.4
Jan 25-0.41
Jan 25-0.48
Jan 25-0.46
Jan 25-0.44
Dec 24-0.44
Dec 24-0.39
Dec 24-0.29
Dec 24-0.23
Nov 24-0.13
Nov 24-0.11
Nov 24-0.03
Nov 24-0.06
Nov 24-0.03
Oct 24-0.2
Oct 240.06
Oct 24-0.15
Oct 24-0.01
Sep 240.41
Sep 240.81
Sep 240.92
Sep 240.76
Aug 241.35
Aug 241.63
Aug 241.06
Aug 241.01
Aug 240.82
Price/Operating Cashflow
0204060med 3.3Jul 24Oct 24May 25Aug 25Nov 25Mar 26Jun 26
PRTT Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Jun 260.56
Jun 260.63
Jun 261.02
Jun 260.55
May 260.55
May 260.84
May 260.84
May 260.84
May 260.56
Apr 260.46
Apr 260.46
Apr 260.46
Apr 260.47
Mar 260.47
Mar 260.58
Mar 260.93
Mar 260.93
Feb 260.7
Feb 260.7
Feb 261.39
Feb 260.56
Jan 260.74
Jan 260.74
Jan 260.46
Jan 260.56
Jan 260.86
Dec 250.93
Dec 250.79
Dec 251.02
Dec 251.13
Nov 251.76
Nov 251.76
Nov 251.82
Nov 251.72
Oct 251.53
Oct 252.05
Oct 252.05
Oct 252.23
Oct 252.21
Sep 251.85
Sep 252.02
Sep 252.66
Sep 251.85
Aug 252.76
Aug 253.38
Aug 253.62
Aug 252.12
Aug 252.91
Jul 254.5
Jul 253.97
Jul 254.63
Jul 255.19
Jun 255.15
Jun 255.15
Jun 255.02
Jun 255.42
May 255.56
May 255.56
May 255.87
May 255.15
May 255.29
Apr 255.97
Apr 255.15
Apr 255.15
Apr 255.87
Dec 242.27
Dec 242.5
Dec 242.96
Dec 243.22
Nov 243.71
Nov 243.79
Nov 244.17
Nov 244.03
Nov 244.17
Oct 243.38
Oct 244.58
Oct 243.61
Oct 244.25
Sep 249.91
Sep 2412.48
Sep 2413.21
Sep 2412.19
Aug 2416
Aug 2417.77
Aug 2414.09
Aug 2413.8
Aug 2412.55
Jul 2413.43
Jul 2413.29
Jul 2416
Jul 2416
Jun 2432.41
Jun 2435.53
Jun 2433.69
Jun 2438.38
May 2432.69
May 2434.82
May 2438.38
May 2441.5
May 2439.09
Price to Book
00.20.40.6med 0.11Oct 24Jan 25May 25Aug 25Nov 25Mar 26Jun 26
PRTT Price to Book by quarter
PeriodPrice to Book
Jun 260.01
Jun 260.01
Jun 260.02
Jun 260.01
May 260.01
May 260.01
May 260.01
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Mar 260.01
Mar 260.01
Mar 260.02
Mar 260.02
Feb 260.01
Feb 260.01
Feb 260.02
Feb 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.02
Dec 250.02
Dec 250.01
Dec 250.02
Dec 250.02
Nov 250.03
Nov 250.03
Nov 250.03
Nov 250.03
Oct 250.03
Oct 250.04
Oct 250.04
Oct 250.04
Oct 250.04
Sep 250.06
Sep 250.06
Sep 250.09
Sep 250.06
Aug 250.09
Aug 250.11
Aug 250.12
Aug 250.07
Aug 250.09
Jul 250.14
Jul 250.13
Jul 250.15
Jul 250.17
Jun 250.2
Jun 250.2
Jun 250.19
Jun 250.21
May 250.21
May 250.21
May 250.22
May 250.2
May 250.2
Apr 250.23
Apr 250.2
Apr 250.2
Apr 250.22
Mar 250.27
Mar 250.26
Mar 250.23
Mar 250.28
Feb 250.19
Feb 250.18
Feb 250.21
Feb 250.15
Jan 250.11
Jan 250.11
Jan 250.09
Jan 250.1
Jan 250.1
Dec 240.11
Dec 240.12
Dec 240.14
Dec 240.15
Nov 240.17
Nov 240.18
Nov 240.19
Nov 240.19
Nov 240.19
Oct 240.16
Oct 240.21
Oct 240.17
Oct 240.2
Sep 240.27
Sep 240.35
Sep 240.37
Sep 240.34
Aug 240.44
Aug 240.49
Aug 240.39
Aug 240.38
Aug 240.35
Protect Pharmaceutical Corporation
PRTT
Stockpicker

Video analysis: PRTT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PRTT

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.